Related Experiment Video
Updated: Apr 4, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
The possible impact of sortilin in reducing HBsAg expression in chronic hepatitis B
Sima Besharat1,2, Aezam Katoonizadeh1, Shirin Moossavi1
1Liver and Pancreatobiliary Diseases Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Insights
Chronic hepatitis B patients show inverse association between hepatic Sortilin-1 (SORT1) gene expression and Hepatitis B surface antigen (HBsAg) levels. This suggests SORT1 may play a role in HBsAg particle formation during HBV infection.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Hepatitis B virus (HBV) infection causes chronic liver disease, fibrosis, and cirrhosis globally.
- Hepatitis B surface antigen (HBsAg) is a key marker in HBV infection, reflecting viral load.
- Sortilin-1 (SORT1) is implicated in protein trafficking and degradation pathways.
Purpose of the Study:
- To investigate the relationship between hepatic and serum HBsAg expression and hepatic SORT1 gene expression in chronic HBV patients.
- To explore the potential role of SORT1 in the pathogenesis of chronic hepatitis B.
Main Methods:
- Liver biopsies from 30 chronic hepatitis B patients were analyzed.
- Hepatic HBsAg expression was assessed using immunohistochemistry.
- Hepatic SORT1 gene expression was quantified using quantitative real-time PCR (qRT-PCR).
Main Results:
- 90% of liver biopsies showed positive HBsAg staining.
- A significant inverse association was found between hepatic HBsAg and SORT1 gene expression (β = -0.5, P = 0.042).
- HBV DNA levels correlated with both hepatocyte and serum HBsAg titers, and ALT levels correlated with hepatic activity index.
Conclusions:
- Hepatic SORT1 gene expression is inversely associated with hepatic HBsAg expression in chronic hepatitis B.
- Sortilin-1 may be involved in the formation or regulation of Hepatitis B surface antigen particles.
- Further research is warranted to elucidate the precise role of SORT1 in HBV pathogenesis.
Abstract:
Hepatitis B virus (HBV) infection is a major global health problem. Chronically infected people are at risk for progressive hepatic fibrosis and consequent cirrhosis. Hepatitis B surface antigen (HBsAg) level in serum is a complementary marker for intrahepatic HBV DNA and covalently closed circular DNA (cccDNA). Sortilin-1 (SORT1) has been reported to be involved in the post-Golgi vesicle trafficking of Apo lipoproteins degradation pathways. This study was designed to evaluate the hepatic and serum expression of HBsAg and its association with hepatic SORT1 gene expression in patients with chronic HBV. Thirty chronic hepatitis B patients with histological examination results were enrolled in this study. Liver biopsies were analyzed for hepatic HBsAg and SORT1 gene expression by immunohistochemistry and quantitative real time PCR (qRT-PCR), respectively. Twenty seven out of 30 (90%) liver biopsies had positive staining for HBsAg and showed a significant inverse association with hepatic SORT1 fold change gene expression (β = -0.5, P = 0.042). There was significant association between HBV DNA levels and HBsAg expression in hepatocyte or serum titer of HBsAg (r = 0.39, P = 0.029; r = 0.39, P = 0.032 respectively). Serum ALT was also correlated with hepatic activity index (HAI) score (β = 0.6, P = 0.001). Inverse association between hepatic SORT1 gene expression and hepatic HBsAg expression indicates the possible role of sortilin in HBsAg particle formation.
More Related Videos
05:55Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Hepatitis